You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 4, April 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Panic Disorder
 •Alert me on articles by topic

Anxiolyticlike Effects of Atrial Natriuretic Peptide on Cholecystokinin Tetrapeptide–Induced Panic Attacks

Preliminary Findings

Klaus Wiedemann, MD; Holger Jahn, MD; Alexander Yassouridis, PhD; Michael Kellner, MD

Arch Gen Psychiatry. 2001;58:371-377.

Background  Panic attacks induced by administration of cholecystokinin tetrapeptide (CCK-4) have been evaluated as a valuable tool to investigate the neurobiological mechanisms involved in panic anxiety. The rationale to study the effects of natriuretic peptides on the CCK-4 response is derived from observations that atrial natriuretic peptide (ANP) is released during panic attacks in humans and has anxiolyticlike actions in various animal models.

Methods  A double-blind, placebo-controlled design was conducted in 9 patients with panic disorder and 9 similar healthy control subjects. After pretreatment with an infusion of 150 µg of ANP or placebo in random order, each subject received 50 µg of CCK-4. Psychopathological parameters as well as physiological measures were sampled before and after CCK-4 administration.

Results  After pretreatment with ANP, the number of CCK-4–induced panic attacks decreased from 8 to 6 in patients and from 5 to 2 in controls. Acute Panic Inventory ratings were significantly reduced in patients after ANP vs placebo pretreatment. Infusion of ANP significantly curtailed the CCK-4–induced release of corticotropin in patients. Heart rate variability analysis indicated a sympathetic stimulation by CCK-4 that was inhibited by ANP in patients and controls.

Conclusions  The present study indicates that ANP exerts anxiolyticlike effects on CCK-4–stimulated anxiety attacks in patients with panic disorder. In addition, ANP produced an inhibition of the hypothalamopituitary-adrenocortical system and sympatholytic effects.


From the Department of Psychiatry and Psychotherapy, University of Hamburg, Hamburg (Drs Wiedemann, Jahn, and Kellner), and Max Planck Institute of Psychiatry, Munich (Drs Wiedemann, Yassouridis, and Kellner), Germany.

Corresponding author and reprints: Klaus Wiedemann, Department of Psychiatry and Psychotherapy, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany (e-mail: wiedeman{at}uke.uni-hamburg.de).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.